EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring the Antimicrobial Efficacy of Mesenchymal Stem Cell Secretome Against Klebsiella pneumoniae in Urinary Tract Infections

Leen Ali, Elie Salem Sokhn, Charbel Khalil, Fatima A Saleh iD

Clinical and Translational Science · 2026-06 · 19 (6)

DOI: 10.1111/cts.70630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 11.06.2026. Verfasst von Leen Ali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon. Hauptthemen laut MEDLINE: Urinary Tract Infections, Mesenchymal Stem Cells, beta-Lactamases. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) has become a global health crisis, with Klebsiella pneumoniae ( K. pneumoniae ) emerging as a major driver of AMR and a leading cause of urinary tract infections (UTIs). Mesenchymal stem cell (MSC)‐derived secretomes have gained attention for their antimicrobial properties. This study aimed to investigate the antibacterial activity of MSC‐derived secretomes against urinary K. pneumoniae isolates. The secretomes derived from adipose tissue (AD‐MSCs), bone marrow (BM‐MSCs), and umbilical cord (UC‐MSCs) were tested against 50 K. pneumoniae clinical strains isolated from urine, including extended‐spectrum β ‐lactamase (ESBL)‐, AmpC‐, and carbapenem‐resistant (CRE) strains. This secretome inhibited 68% of isolates overall, including 81.5% of K. pneumoniae (non‐ESBL, non‐AmpC, non‐CRE), 46.7% of ESBL‐, and 100% of AmpC‐producing isolates, but showed no effect on CRE isolates. Genotypic analysis revealed that all ESBL‐producing isolates (100%) harbored the blaSHV gene and expressed the fimH , wabG , uge , ureA , and entB virulence factors. These findings demonstrate, for the first time, the antibacterial potential of three distinct MSC secretome sources against K. pneumoniae , highlighting their promise as a novel adjunctive therapy for drug‐resistant UTIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsMesenchymal Stem Cellsbeta-LactamasesKlebsiella pneumoniaeSecretomeKlebsiella InfectionsVirulence FactorsHumans

Stichwörter der Autor:innen

Klebsiella pneumoniaeantimicrobial resistancemesenchymal stem cellssecretomestem cell therapyurinary tract infections

Substanzen

beta-LactamasesVirulence Factors

Autor:innen und Institutionen

  • Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon.
  • Reviva Regenerative Medicine Center, Bsalim, Lebanon.
  • Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, UAE.
  • Lebanese American University, School of Medicine, Beirut, Lebanon.

ORCID-Profile: Fatima A Saleh

Zitieren

APA

Ali, L., Sokhn, E. S., Khalil, C., & Saleh, F. A. (2026). Exploring the Antimicrobial Efficacy of Mesenchymal Stem Cell Secretome Against Klebsiella pneumoniae in Urinary Tract Infections. Clinical and Translational Science, 19(6). https://doi.org/10.1111/cts.70630

Vancouver

Ali L, Sokhn ES, Khalil C, Saleh FA. Exploring the Antimicrobial Efficacy of Mesenchymal Stem Cell Secretome Against Klebsiella pneumoniae in Urinary Tract Infections. Clinical and Translational Science. 2026;19(6). doi:10.1111/cts.70630

BibTeX
@article{Ali2026,
  author = {Ali, Leen and Sokhn, Elie Salem and Khalil, Charbel and Saleh, Fatima A},
  title = {Exploring the Antimicrobial Efficacy of Mesenchymal Stem Cell Secretome Against Klebsiella pneumoniae in Urinary Tract Infections},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.1111/cts.70630}
}
Kostenlos starten →